benralizumab(Fasenra)
Anti-IL-5R-alpha monoclonal antibody
Pronunciation
/bɛnrəˈlɪzʊmæb/
International Phonetic Alphabet (IPA). Say it aloud once — you will remember it forever.
At a glance
- Generic name
- benralizumab
- Brand names
- Fasenra
- Therapeutic class
- Anti-IL-5R-alpha monoclonal antibody
- Mechanism (summary)
- <!-- AI-DRAFTED: 2026-06-24 -->
Clinical pearls
- Auto-injector option for at-home use after training.
- Loading every 4 weeks x 3 doses, then maintenance every 8 weeks (less frequent than mepolizumab).
- Causes nearly complete eosinophil depletion.
- Treat pre-existing helminth infection.
- ### NAPLEX practice notes
Sources
See how benralizumab appears in NAPLEX-style questions
PharmDHub Premium includes a full drug card, dosing, boxed warnings, drug-drug interactions, and practice questions built around this drug.